Development of a rapid and sensitive LC–MS/MS assay for the determination of sorafenib in human plasma
- 26 October 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 46 (2), 362-367
- https://doi.org/10.1016/j.jpba.2007.10.027
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assayJournal of Chromatography B, 2007
- Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5Cancer Research, 2006
- Discovery and development of sorafenib: a multikinase inhibitor for treating cancerNature Reviews Drug Discovery, 2006
- The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006Oncogene, 2005
- Determination of 2‐methoxyestradiol in human plasma, using liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2005
- Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid TumorsJournal of Clinical Oncology, 2005